Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Uncover the advantages of investing in gold versus savings accounts. Learn which option suits your financial goals better.
23,656 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
As investors pivot away from high-flying tech, the financial sector could offer underappreciated value. This guide ex...
Leonardo stock trounced market today as investors rotated into defense contractors amid earnings signals and budget h...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
A notable stake in Magnite signals a contrarian take on the ad tech landscape. This article breaks down the move, wha...
When OppFi shares their Q4 2025 earnings, investors want clarity on profitability, credit quality, and growth. This g...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
American Express has fallen notably in 2026, prompting questions about whether the drop makes it a bargain. This arti...
NVIDIA stunned markets with a trillion-dollar order pipeline, but the stock hardly moved. This piece explains what th...